Lindsey Roeker

22PUBLICATIONS
191CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 05, 2026
Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.

|Jul 22, 2026
Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors.

|Jun 30, 2026
Zanubrutinib, obinutuzumab, and venetoclax in CLL: long-term follow up, MRD kinetics, retreatment, T-cell profiling, and PKs.

|Feb 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia.

Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia

|Oct 07, 2025
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.

Jennifer R Brown, Bastien Nguyen, Sai Prasad Desikan

|Oct 14, 2024
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.

Kuo-Kai Chin, Andriy Derkach, Christopher Famulare

Pageof 4

Frequent Collaborators

6 joint publications

Andrew Zelenetz

5 joint publications

Meghan C Thompson

4 joint publications

Jennifer A Woyach

4 joint publications

Toby A Eyre